Upper Airway Obstruction in Parkinson's Disease

Standaert D.G. , Stern M.B. Update on the management of Parkinson's Disease. Med Clin North Am 1993; 77: 169–183.

Vincken W.G. , Gauthier S.G. , Dolfuss R.E. , Hanson R.E. , Daravay C.M. , Cosio M.G. Involvement of upper-airway muscles in extrapyramidal disorders; a cause of airflow limitation. N Engl J Med 1984; 311: 438–42.

Backus W.W. , Ward R. , Vitkun S. , Fitzgerald D. , Askanazi J. Post extubation laryngeal spasm in an unaesthetised patient with Parkinson's disease. J Cin Anaesth 1991; 3: 314–316.

Hoehn M.M. , Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427–42.

Neu H.C. , Connolly J.J. , Schwertley F.W. , Ladwig H.A. , Brody A.W. Obstructive respiratory dysfunctin in parkinsonian patients. Am Rev Resp Dis 1967; 95: 33–47.

Obenour W.H. , Stevens P.M. , Cohen A.A. , McCutchen J.J. The causes of abnormal pulmonary function in Parkinson's Disease. Am Rev Resp Dis 1972; 105: 382–7.

Hovestadt A. , Bogaard J.M. , Meerwaldt J.D. , Vander der Meche F.G.A. , Stigt J. Pulmonary function in Parkinson's Disease. J Neurol, Neurosurg, Psych 1989; 52: 329–333.

Estenne M. , Hubert M. , De Troyer A. Respiratory Muscle Involvement in Parkinson's Disease. Lancet 1984; 311: 1516.

Zupnick H.M. , Brown L.K. , Miller A. , Moros D.A. Respiratory Dysfunction due to L-Dopa Therapy for Parkinsonism: Diagnosis Using Serial Pulmonary Function Tests and Respiratory Inductive Plethysmograph. Am J Med 1990; 86: 109–114.

Vincken W.G. , Darauay C.M. , Cosio M.G. Reversibility of Upper Airway Obstruction after Levodopa Therapy in Parkinson's Disease. Chest 1989; 96: 210–12.

Corbin D.O.C. , Williams A.C. Stridor during dystonic phases of Parkinson's Disease. J Neurol Neurosurg Psych 1987; 50: 821.

Brescia Morra V. , Polverino M. , De Luca G. , Landi P. , Galdi A. , Campanella G. Upper Airway Muscles Dysfunction and Levodopa Responsiveness in Parkinson's Disease. Acta Neurol Napoli 1992; 14: 512–18.

Riley D.E. , Grossman G. , Martin L. Acute respiratory failure from dopamine agonist withdrawal. Neurology 1992; 42: 1843–44.

Barach E. , Dubin L.M. , Tomlanovic M.C. , Kottamasu S. Dystonia presenting as upper airway obstruction. J Emerg Med 1989; 7: 237–40.

Caine D. Treatment of Parkinson's Disease. N Engl J Med 1993; 329: 1021–27.

Kurth M.C. , Tetrud J.W. , Tanner M.D. Double blind, placebo- controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's Disease patients with “on- off” fluctuations. Neurology 1993; 43: 1698–1703.

Rosin A.J. , Devereux D. , Eng N. , Caine D.B. Parkinsonism with “On-Off’ Phenomena. Intravenous treatment with Levodopa after major abdominal surgery. Arch Neurol 1979; 36: 32–34.

Bredberg E. , Nilsson D. , Johansson K. Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's Disease. Eur J Clin Pharm 1993; 45: 117–122.

Frankel J.P. , Lees A.J. , Kempster P.A. , Stern G.M. Subcutaneous apomorphine in the treatment of Parkinson's Disease. J Neurol Neurosurg Psych 1990; 53: 96–101.

Brousselle E. , Marion M.H. , Poliak P. Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery. Lancet 1992; 340: 859–860.